Top Markets
Coin of the day
Genetron Holdings Limited Genetron Holdings Limited

Genetron Holdings Limited

GTH
Rang in Aktien #15212
Genetron Holdings Limited (GTH) is a precision oncology company that... Genetron Holdings Limited (GTH) is a precision oncology company that specializes in cancer molecular profiling, utilizing advanced molecular biology and data science to enhance cancer treatment. The company delivers a range of services, including diagnosis, monitoring, and early screening, primarily through its proprietary laboratory-developed tests. Its product offerings encompass a variety of in-vitro diagnostic (IVD) solutions. These include the 8-gene lung cancer assay, an IVD product for lung cancer detection; the Genetron 3D biochip reading instrument; and the Genetron S5, a semiconductor-based next-generation sequencing (NGS) system that identifies nucleotides by detecting pH changes. Other key products are the Genetron Chef System, the production-scale Genetron S2000 sequencing platform, and Onco PanScan, a genomic profiling service for diverse solid tumors. Moreover, Genetron provides specialized assays such as the IDH1 and TERT gene assays for glioma, a fundamental thyroid assay for thyroid tumors, a platelet-derived growth factor receptor alpha assay for GIST cancer, and HCCscan, a qPCR-based assay designed to detect hepatocellular carcinoma. Beyond its direct services and products, the company offers genomics research and clinical development services, often in collaboration with biopharmaceutical companies globally. Genetron has also established a strategic partnership with JD Health to develop holistic solutions for comprehensive cancer management. The company was founded in 2015 and has its headquarters in Beijing, People's Republic of China.
Aktienkurs
$4.03
Zuletzt synchronisiert: 2024-03-28
Marktkapitalisierung
$366.11M
Veränderung (1 Tag)
0.25%
Veränderung (1 Jahr)
0.00%
Land
CN
Handel Genetron Holdings Limited (GTH)

Kategorie

Preis GTH mit Marktkapitalisierung von B
Genetron Holdings Limited Genetron Holdings Limited
GTH
$4.03
Marktkapitalisierung von Genetron Holdings Limited(GTH)
Marktkapitalisierung: $366.11M
Mit Stand September 2026 hat Genetron Holdings Limited eine Marktkapitalisierung von $366.11M. Das macht Genetron Holdings Limited laut unseren Daten zum 15212th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Genetron Holdings Limited von 2020 bis 2026
GTH im Vergleich zu den Top 5 der beliebtesten stocks
Preis für GTH Vermögenswert B Marktkapitalisierung von B Ergebnisse
Genetron Holdings Limited Genetron Holdings Limited
$58,635.34 $366.11M
$5.327T +1,454,871.21%
Genetron Holdings Limited Genetron Holdings Limited
$51,128.96 $366.11M
$4.645T +1,268,608.59%
Genetron Holdings Limited Genetron Holdings Limited
$44,803.81 $366.11M
$4.070T +1,111,657.10%
Genetron Holdings Limited Genetron Holdings Limited
$41,659.16 $366.11M
$3.785T +1,033,625.99%
Genetron Holdings Limited Genetron Holdings Limited
$30,712.57 $366.11M
$2.790T +761,998.39%